Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
8 hedge funds and large institutions have $1.54M invested in Yield10 Bioscience, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
20% less capital invested
Capital invested by funds: $1.92M → $1.54M (-$375K)
33% less funds holding
Funds holding: 12 → 8 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
+$326K |
| 2 |
Two Sigma Investments
New York
|
+$138K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$307K |
| 2 |
Renaissance Technologies
New York
|
-$85.6K |
| 3 |
First Manhattan
New York
|
-$2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.82K |
| 5 |
Morgan Stanley
New York
|
-$303 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Cannell & Co
New York
| $836K | +$326K | +2,146 | +55% |
|
|
2
Renaissance Technologies
New York
| $245K | -$85.6K | -564 | -24% |
|
3
BlackRock
New York
| $218K | – | – | – |
|
|
4
Two Sigma Investments
New York
| $126K | +$138K | +908 | New |
|
|
BC
5
Birchview Capital
Burlington,
Vermont
| $110K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $7K | +$2.58K | +17 | +57% |
|
|
HDIM
7
Hanson & Doremus Investment Management
Burlington,
Vermont
| $1K | – | – | – |
|
|
WVP
8
Worth Venture Partners
Fort Lee,
New Jersey
| – | -$307K | -1,647 | Closed |
|
|
9
First Manhattan
New York
| – | -$2K | -14 | Closed |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$1.82K | -12 | Closed |
|
|
11
Morgan Stanley
New York
| – | -$303 | -2 | Closed |
|
YTEN Hedge Fund Activity: Q4 2020 in Review
8 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2020, worth a combined $1.54M — down 20% from $1.92M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of YTEN and 1 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Cannell & Co, adding an estimated $326K. The largest seller was Worth Venture Partners, exiting entirely with an estimated $307K sold.
- 8 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2020, down from 12 in Q3 2020.
- Funds reported $1.54M of Yield10 Bioscience, Inc. Common Stock stock for Q4 2020, down 20% quarter-over-quarter.
- 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2020 and 5 closed out, a net change of -4 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2020 was Cannell & Co, an estimated $326K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2020 was Worth Venture Partners, an estimated $307K sold.
Based on aggregated 13F filings for Q4 2020.